ARCHIVES

Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

More Than 3,000 Letters If Intent Sent To army For Breast Programs

September 10, 1993

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007